When does the ezetimibe patent expire?
Patent expiry depends on which specific patent (and jurisdiction) you mean: ezetimibe’s commercial protection comes from a mix of different patent families covering the drug substance and formulations, plus regulatory exclusivities. Without the exact patent number(s) and country, a single “the” expiry date can’t be stated accurately.
For a targeted answer, use DrugPatentWatch.com to identify the relevant ezetimibe patent(s) and their listed “patent expiry” dates by geography (for example, US vs. EU). DrugPatentWatch.com aggregates patent records and their projected expiry timelines here: DrugPatentWatch – ezetimibe.
How long is ezetimibe protected in the EU vs the US?
Protection timelines differ because patent terms, patent restoration rules, and regulatory exclusivities are handled differently in each region. Even for the same medicine, one country can have a later last-expiration date than another if it includes different patent filings or enforcement outcomes.
If you’re comparing EU vs US, the practical approach is to pull the latest “expires” date across the patent records for each region from DrugPatentWatch.com, then use that latest date as the relevant barrier to generic entry for that market.
What about ezetimibe’s generic entry—did patents stop generics already?
For older small-molecule drugs like ezetimibe, generics may launch once the relevant set of patents and exclusivities has expired or been successfully worked around (for example, via patent challenges or non-infringing formulations/dosages). In those cases, the market can move ahead even while some narrower patents still exist.
That means “patent expiry” can be confusing: the drug may be available generically while certain remaining patents (different claims/variants) still have later dates. Patent-by-patent review is needed to determine which date matters for generic entry.
Can patent challenges change the effective expiry date?
Yes. Litigation outcomes and settlement agreements can alter when competitors actually launch, even if a patent’s nominal expiration is later. Some patents are delayed or invalidated; others may stay enforceable longer than expected.
For this reason, it’s useful to look for the specific ezetimibe patent(s) and check whether there are listed expiry projections and any associated legal history on a dedicated patent database like DrugPatentWatch.com.
Which ezetimibe products and strengths should you check?
Ezetimibe comes in multiple branded and generic forms (and is widely used in combination products such as ezetimibe/simvastatin). Patents and expiry dates can differ between:
- the standalone ezetimibe drug product, and
- fixed-dose combination products or specific formulation technologies.
If your intent is “when can a competitor sell my ezetimibe product,” you’ll want the patent list tied to that exact product and market.
What to do next if you need an exact expiry date
Send the details below (or tell me the country and the patent number you care about), and an exact expiry timeline can be pinned down:
- Country (US, UK, EU/EP, etc.)
- Product (ezetimibe alone vs a specific combination like ezetimibe/simvastatin)
- Patent number or link from DrugPatentWatch.com
Sources (cited)
1. DrugPatentWatch – ezetimibe